Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
ID: 356362Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356362

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-291.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among scientists and build a nationwide cohort dedicated to advancing the understanding of cancer disparities, ultimately leading to future R01 projects. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the closing date for submissions is November 16, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-291-Full-Announcement.html
    PAR-24-291.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support basic research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations. The program encourages innovative pilot studies and the development of methodologies to understand the mechanisms underlying unequal cancer incidence and outcomes. Applications for this funding can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years and an emphasis on exploratory research. Investigators are encouraged to focus on projects examining the intersection of race and cancer biology while utilizing biospecimens and diverse population datasets. The initiative seeks to build a cohort of researchers dedicated to advancing the understanding of cancer disparities, moving toward mechanistic studies through future R01 projects. This funding opportunity highlights NIH's commitment to addressing the complex biological factors behind cancer disparities and aims to foster collaboration among scientists to enhance resources and research methodologies in the field.
    Similar Opportunities
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research" (R21 Clinical Trial Not Allowed). This funding opportunity aims to enhance diversity among early-stage and junior investigators in cancer research, particularly from groups that are underrepresented in the biomedical, behavioral, clinical, and social sciences. The initiative encourages innovative studies in cancer biology, with a maximum funding amount of $275,000 available over a two-year period, and applications must demonstrate scientific merit and innovation. The application window opens on May 17, 2024, with the first awards expected to be made in June 2024; interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Administrative Supplement funding opportunity aimed at enhancing cancer disparities research through the initiative PAR-22-114. This program encourages collaborations between seasoned cancer researchers and those focused on cancer disparities, with the goal of addressing adverse differences in cancer outcomes among racial/ethnic minorities and underserved populations. The funding supports the expansion of existing NCI-funded research projects to include feasibility studies on various cancer types, with a total funding amount of $2.55 million available for up to 10 awards, each with a budget limit of $150,000 in direct costs over a 12-month period. Interested applicants must submit their proposals by January 23, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R01 Research Project Grant to enhance cancer screening and preventive services for populations experiencing health disparities. This initiative aims to address barriers to cancer care by developing interventions that operate at multiple levels, including patient, clinician, healthcare settings, and community factors, while encouraging collaboration with community partners. The funding reflects NIH's commitment to advancing health equity, particularly for historically underserved groups, and requires applicants to submit a Plan for Enhancing Diverse Perspectives. Interested applicants can find more information and guidelines at the provided link, with applications due by January 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Co-infection and Cancer (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Co-infection and Cancer (R21 Clinical Trial Not Allowed)" aimed at enhancing research on the mechanisms and epidemiology of co-infections in relation to cancer development. This grant seeks innovative proposals that investigate how co-infections, particularly those involving known oncogenic agents (excluding HIV), may influence carcinogenesis and contribute to cancer disparities among diverse populations. The maximum funding amount available for each application is $275,000 over a two-year period, with applications due by November 16, 2025. Eligible applicants include a wide range of institutions and organizations, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.